1.Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures?
Campbell George SAMUEL ; McIvor Andrew R. ; Joanis VINCENT ; Urquhart Graydon DAVID
World Journal of Emergency Medicine 2011;2(4):272-278
BACKGROUND: Blood cultures (BC ) are commonly ordered during the initial assessment of patients with community-acquired pneumonia (CAP), yet their yield remains low. Selective use of BC would allow the opportunity to save healthcare resources and avoid patient discomfort. The study was to determine what demographic and clinical factors predict a greater likelihood of a positive blood culture result in patients diagnosed with CAP. METHODS: A structured retrospective systematic chart audit was performed to compare relevant demographic and clinical details of patients admitted with CAP, in whom blood culture results were positive, with those of age, sex, and date-matched control patients in whom blood culture results were negative. RESULTS: On univariate analysis, eight variables were associated with a positive BC result. After logistic regression analysis, however, the only variables statistically significantly associated with a positive BC were WBC less than 4.5 x 109/L [likelihood ratio (LR): 7.75, 95% CI=2.89-30.39], creatinine >106 μmol/L (LR: 3.15, 95%CI=1.71-5.80), serum glucose<6.1 mmol/L (LR: 2.46, 95%CI=1.14-5.32), and temperature > 38 °C (LR: 2.25, 95% CI =1.21-4.20). A patient with all of these variables had a LR of having a positive BC of 135.53 (95% CI=25.28-726.8) compared to patients with none of these variables. CONCLUSIONS: Certain clinical variables in patients with CAP admitted to hospitals do appear to be associated with a higher probability of a positive yield of BC, with combinations of these variables increasing this likelihood. We have identified a subgroup of CAP patients in whom blood cultures are more likely to be useful.
2.Prolonged Regression of Metastatic Leptomeningeal Breast Cancer That Has Failed Conventional Therapy: A Case Report and Review of the Literature.
Andrew VINCENT ; Glenn LESSER ; Doris BROWN ; Tamara VERN-GROSS ; Linda METHENY-BARLOW ; Julia LAWRENCE ; Michael CHAN
Journal of Breast Cancer 2013;16(1):122-126
Approximately 5% of breast cancer patients develop leptomeningeal metastases over the course of their disease. Though several treatments options are available for these patients, their prognosis is typically considered to be poor. We report a case of leptomeningeal failure after a patient underwent prior radiotherapy, radiosurgery, surgery, chemotherapy, and biologic therapy. This patient experienced a prolonged response after receiving bevacizumab and capecitabine. The literature currently contains several reports regarding the use of systemic therapy to manage leptomeningeal metastases from breast cancer, which we summarize. Finally, we review the relevant effects of the patient's treatment modalities and provide a rationale for the mechanism that led to her prolonged response.
Antibodies, Monoclonal, Humanized
;
Biological Therapy
;
Breast
;
Breast Neoplasms
;
Deoxycytidine
;
Fluorouracil
;
Humans
;
Meningeal Neoplasms
;
Neoplasm Metastasis
;
Prognosis
;
Radiosurgery
;
Bevacizumab
;
Capecitabine
3.Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Sung Jong LEE ; Andrew YANG ; T C WU ; Chien Fu HUNG
Journal of Gynecologic Oncology 2016;27(5):e51-
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic agents. However, despite the various treatments utilized for the treatment of cervical cancer, its disease burden remains a global issue. Persistent infection of human papillomavirus (HPV) has been identified as an essential step of pathogenesis of cervical cancer and many other cancers, and nation-wide HPV screening as well as preventative HPV vaccination program have been introduced globally. However, even though the commercially available prophylactic HPV vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline), are effective in blocking the entry of HPV into the epithelium of cervix through generation of HPV-specific neutralizing antibodies, they cannot eliminate the pre-existing HPV infection. For these reason, other immunotherapeutic options against HPV-associated diseases, including therapeutic vaccines, have been continuously explored. Therapeutic HPV vaccines enhance cell-mediated immunity targeting HPV E6 and E7 antigens by modulating primarily dendritic cells and cytotoxic T lymphocyte. Our review will cover various therapeutic vaccines in development for the treatment of HPV-associated lesions and cancers. Furthermore, we will discuss the potential of immune checkpoint inhibitors that have recently been adopted and tested for their treatment efficacy against HPV-induced cervical cancer.
Dendritic Cells/immunology
;
Female
;
Genetic Vectors
;
Humans
;
*Immunotherapy
;
Papillomavirus Infections/*complications/therapy
;
Papillomavirus Vaccines/therapeutic use
;
*Translational Medical Research
;
Uterine Cervical Neoplasms/*therapy
;
Vaccines, DNA/therapeutic use
;
Vaccines, Subunit/therapeutic use
4.Epstein-Barr virus and Burkitt lymphoma.
Martin ROWE ; Leah FITZSIMMONS ; Andrew I BELL
Chinese Journal of Cancer 2014;33(12):609-619
In 1964, a new herpesvirus, Epstein-Barr virus (EBV), was discovered in cultured tumor cells derived from a Burkitt lymphoma (BL) biopsy taken from an African patient. This was a momentous event that reinvigorated research into viruses as a possible cause of human cancers. Subsequent studies demonstrated that EBV was a potent growth-transforming agent for primary B cells, and that all cases of BL carried characteristic chromosomal translocations resulting in constitutive activation of the c-MYC oncogene. These results hinted at simple oncogenic mechanisms that would make Burkitt lymphoma paradigmatic for cancers with viral etiology. In reality, the pathogenesis of this tumor is rather complicated with regard to both the contribution of the virus and the involvement of cellular oncogenes. Here, we review the current understanding of the roles of EBV and c-MYC in the pathogenesis of BL and the implications for new therapeutic strategies to treat this lymphoma.
B-Lymphocytes
;
Burkitt Lymphoma
;
virology
;
Herpesvirus 4, Human
;
Humans
;
Translocation, Genetic
5.Adjustment of Malpositioned Woven EndoBridge Device Using Gooseneck Snare: Complication Management Technique
Krishna AMULURU ; Fawaz AL-MUFTI ; Daniel H. SAHLEIN ; John SCOTT ; Andrew DENARDO
Neurointervention 2021;16(3):275-279
The Woven EndoBridge (WEB) is an intrasaccular flow-disrupting device for the treatment of wide-necked saccular cerebral aneurysms. As with any neuroendovascular device, complications in the form of malpositioning and migration must be managed quickly and safely. Few studies have reported complication management techniques in instances of dislocated or migrated WEB devices. We retrospectively describe a case of a malpositioned WEB device that was successfully adjusted with the use of a gooseneck snare. Multiple other intra-procedural bailout strategies for management of WEB malposition and migration were considered, and are herein discussed. Operators should be aware of the causes of WEB malposition and a variety of bailout strategies.
6.Tick killing in situ before removal to prevent allergic and anaphylactic reactions in humans: a cross-sectional study
Benjamin William Phillips TAYLOR ; Andrew RATCHFORD ; Sheryl VAN NUNEN ; Brian BURNS
Asia Pacific Allergy 2019;9(2):e15-
BACKGROUND: Tick anaphylaxis is a potentially fatal outcome of improper tick removal and management. OBJECTIVE: To investigate whether killing ticks in-situ with ether-containing sprays or permethrin cream, before careful removal by the mouthparts could reduce this risk. METHODS: This was a prospective study at Mona Vale Hospital Emergency Department (ED) in Sydney, New South Wales, over a 6-month period during the peak tick season of 2016. Tick removal methods, allergic/anaphylactic reactions were recorded for patients presenting with ticks in situ or having already removed the ticks themselves. Primary endpoint was allergic/anaphylactic reaction after tick killing/removal. RESULTS: One hundred twenty-one patients met study inclusion criteria. Sixty-one patients (28 known tick-hypersensitive) had ticks killed with Wart-Off Freeze or Lyclear Scabies Cream (5% w/w permethrin) before removal with fine-tipped forceps or Tick Twister. Three patients (2 known tick-hypersensitive) had allergic reactions (5%), none anaphylactic. The 2 known hypersensitive patients suffered reactions during the killing process and the third patient had a particularly embedded tick meaning it could not be removed solely by mouthparts. Fifty patients presented to the ED posttick removal by various methods, none using either fine-tipped forceps or Tick Twister, of which 43 (86%) experienced allergic reactions – 2 anaphylactic. Five patients suffered allergic reactions before presentation despite no attempt at kill or removal, but ticks had likely been disturbed by some other method. Five patients had live ticks removed in ED – 3 refused killing and had no reaction despite 1 having known hypersensitivity; 2 had ticks on eyelids contraindicating killing, 1 with known hypersensitivity but both had allergic reactions post removal. CONCLUSION: Results support killing ticks in-situ before careful removal by mouthparts to reduce allergic/anaphylactic reactions although further research is still required.
Anaphylaxis
;
Cross-Sectional Studies
;
Emergency Service, Hospital
;
Eyelids
;
Fatal Outcome
;
Homicide
;
Humans
;
Hypersensitivity
;
Methods
;
New South Wales
;
Permethrin
;
Prospective Studies
;
Scabies
;
Seasons
;
Surgical Instruments
;
Tick Bites
;
Tick Toxicoses
;
Ticks
7.Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines.
Maryam RAHMAN ; Karina REYNER ; Loic DELEYROLLE ; Sebastien MILLETTE ; Hassan AZARI ; Bryan W DAY ; Brett W STRINGER ; Andrew W BOYD ; Terrance G JOHNS ; Vincent BLOT ; Rohit DUGGAL ; Brent A REYNOLDS
Anatomy & Cell Biology 2015;48(1):25-35
Certain limitations of the neurosphere assay (NSA) have resulted in a search for alternative culture techniques for brain tumor-initiating cells (TICs). Recently, reports have described growing glioblastoma (GBM) TICs as a monolayer using laminin. We performed a side-by-side analysis of the NSA and laminin (adherent) culture conditions to compare the growth and expansion of GBM TICs. GBM cells were grown using the NSA and adherent culture conditions. Comparisons were made using growth in culture, apoptosis assays, protein expression, limiting dilution clonal frequency assay, genetic affymetrix analysis, and tumorigenicity in vivo. In vitro expansion curves for the NSA and adherent culture conditions were virtually identical (P=0.24) and the clonogenic frequencies (5.2% for NSA vs. 5.0% for laminin, P=0.9) were similar as well. Likewise, markers of differentiation (glial fibrillary acidic protein and beta tubulin III) and proliferation (Ki67 and MCM2) revealed no statistical difference between the sphere and attachment methods. Several different methods were used to determine the numbers of dead or dying cells (trypan blue, DiIC, caspase-3, and annexin V) with none of the assays noting a meaningful variance between the two methods. In addition, genetic expression analysis with microarrays revealed no significant differences between the two groups. Finally, glioma cells derived from both methods of expansion formed large invasive tumors exhibiting GBM features when implanted in immune-compromised animals. A detailed functional, protein and genetic characterization of human GBM cells cultured in serum-free defined conditions demonstrated no statistically meaningful differences when grown using sphere (NSA) or adherent conditions. Hence, both methods are functionally equivalent and remain suitable options for expanding primary high-grade gliomas in tissue culture.
Animals
;
Apoptosis
;
Brain
;
Caspase 3
;
Culture Techniques
;
Glioblastoma
;
Glioma*
;
Humans
;
Laminin
;
Neoplastic Stem Cells
;
Stem Cells*
;
Tics
;
Tubulin
8.Which dialysis method should be used for patients with COVID-19?
Patricia Maria Gregoria Mina-Cuañ ; o ; Cary Amiel G. Villanueva ; John Jefferson V. Besa ; Andrew Rufino M. Villafuerte ; Jayson M. Villavicencio ; Vincent Anthony S. Tang ; Lia M. Palileo-Villanueva
Acta Medica Philippina 2020;54(Rapid Reviews on COVID19):120-124
Key Findings
• Very low-quality evidence from a single retrospective study suggests that continuous renal replacement
therapy (CRRT) may reduce mortality among COVID-19 patients on invasive mechanical ventilation. Guidelines
recommend CRRT for critically ill patients to minimize the risk of possible transmission, if this option is available.
• Although uncommon, acute kidney injury (AKI) can occur in association with coronavirus disease 2019
(COVID-19) and is associated with increased in-hospital mortality.
• There are currently no published or ongoing clinical trials directly comparing dialysis modalities for acute
kidney injury in COVID-19 patients.
• In reducing the risk of transmission during dialysis: currently, there are no studies comparing one dialysis
modality to another. The method of dialysis is still primarily determined by the clinical picture of the patient, the
expertise of the center, and the resources available. The American Society of Nephrology (ASN) recommends
CRRT over intermittent hemodialysis (IHD) for critically ill patients with COVID-19 to minimize patient contact
when it is available, and resources allow. Otherwise, intermittent hemodialysis may be done provided that,
infection control measures are strictly followed.
• Several international and local guidelines recommend strict adherence to infection prevention and control
measures (e.g. hand hygiene, physical distancing, proper use of personal protective equipment (PPE), and
cohorting of patients) who are undergoing dialysis.
Covid-19